- Report
- August 2025
- 192 Pages
Global
From €3157EUR$3,545USD£2,755GBP
€3508EUR$3,939USD£3,061GBP
- Report
- October 2025
- 181 Pages
Global
From €3157EUR$3,545USD£2,755GBP
€3508EUR$3,939USD£3,061GBP
- Report
- October 2025
- 187 Pages
Global
From €3157EUR$3,545USD£2,755GBP
€3508EUR$3,939USD£3,061GBP
- Report
- September 2025
- 250 Pages
Global
From €3998EUR$4,490USD£3,490GBP
- Report
- July 2025
- 175 Pages
Global
From €3998EUR$4,490USD£3,490GBP
- Report
- July 2025
- 175 Pages
Global
From €3998EUR$4,490USD£3,490GBP
- Report
- May 2025
- 175 Pages
Global
From €3998EUR$4,490USD£3,490GBP
- Report
- May 2025
- 175 Pages
Global
From €3998EUR$4,490USD£3,490GBP
- Report
- February 2025
- 200 Pages
Global
From €3998EUR$4,490USD£3,490GBP
- Report
- February 2025
- 200 Pages
Global
From €3998EUR$4,490USD£3,490GBP
- Report
- June 2025
- 185 Pages
Global
From €4007EUR$4,500USD£3,497GBP
- Drug Pipelines
- April 2025
- 60 Pages
Global
From €1069EUR$1,200USD£933GBP
€1336EUR$1,500USD£1,166GBP
- Drug Pipelines
- June 2025
- 200 Pages
Global
From €2484EUR$2,789USD£2,168GBP
- Report
- May 2024
- 137 Pages
Global
From €4919EUR$5,524USD£4,293GBP
€5787EUR$6,499USD£5,051GBP
- Report
- May 2024
- 138 Pages
Global
From €4919EUR$5,524USD£4,293GBP
€5787EUR$6,499USD£5,051GBP
- Report
- May 2023
- 103 Pages
Global
From €3500EUR$4,210USD£3,162GBP

Risedronate is a medication used to treat and prevent osteoporosis, a condition characterized by weak and brittle bones. It belongs to a class of drugs known as bisphosphonates, which work by slowing down the rate of bone breakdown and increasing bone density. Risedronate is also used to treat Paget's disease of bone, a disorder that causes abnormal bone growth and pain. It is available in both oral and intravenous forms.
Risedronate is a widely used drug in the Endocrine and Metabolic Disorders Drugs market. It is used to treat and prevent osteoporosis, a condition that affects millions of people worldwide. It is also used to treat Paget's disease of bone, a rare disorder that causes abnormal bone growth and pain. Risedronate is generally well-tolerated and has few side effects.
Some companies in the Risedronate market include Merck & Co., Inc., Teva Pharmaceuticals, and Mylan N.V. These companies manufacture and distribute the drug in various forms, including tablets, capsules, and injections. Show Less Read more